Empirical Finance’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
21,329
+134
| +0.6% | +$10.5K | 0.09% | 206 |
|
|
2025
Q1 | $1.54M | Buy |
21,195
+461
| +2% | +$33.4K | 0.09% | 202 |
|
|
2024
Q4 | $1.53M | Sell |
20,734
-273
| -1% | -$20.2K | 0.09% | 190 |
|
|
2024
Q3 | $1.39M | Buy |
21,007
+452
| +2% | +$29.8K | 0.08% | 214 |
|
|
2024
Q2 | $1.9M | Sell |
20,555
-1,491
| -7% | -$138K | 0.12% | 153 |
|
|
2024
Q1 | $2.11M | Buy |
22,046
+732
| +3% | +$70K | 0.13% | 158 |
|
|
2023
Q4 | $1.63M | Buy |
21,314
+155
| +0.7% | +$11.8K | 0.11% | 168 |
|
|
2023
Q3 | $1.47M | Buy |
21,159
+1,751
| +9% | +$121K | 0.11% | 168 |
|
|
2023
Q2 | $1.83M | Buy |
19,408
+2,192
| +13% | +$207K | 0.14% | 136 |
|
|
2023
Q1 | $1.42M | Buy |
17,216
+831
| +5% | +$68.7K | 0.13% | 145 |
|
|
2022
Q4 | $1.22M | Buy |
16,385
+1,318
| +9% | +$98.3K | 0.13% | 155 |
|
|
2022
Q3 | $1.25M | Buy |
15,067
+2,497
| +20% | +$206K | 0.15% | 138 |
|
|
2022
Q2 | $1.2M | Buy |
12,570
+688
| +6% | +$65.4K | 0.15% | 132 |
|
|
2022
Q1 | $1.4M | Buy |
11,882
+1,273
| +12% | +$150K | 0.16% | 121 |
|
|
2021
Q4 | $1.37M | Buy |
10,609
+2,841
| +37% | +$368K | 0.16% | 117 |
|
|
2021
Q3 | $879K | Buy |
7,768
+450
| +6% | +$50.9K | 0.13% | 156 |
|
|
2021
Q2 | $758K | Buy |
7,318
+1,010
| +16% | +$105K | 0.12% | 194 |
|
|
2021
Q1 | $575K | Hold |
6,308
| – | – | 0.1% | 191 |
|
|
2020
Q4 | $575K | Buy |
6,308
+1,112
| +21% | +$101K | 0.1% | 191 |
|
|
2020
Q3 | $415K | Buy |
5,196
+1,126
| +28% | +$89.9K | 0.09% | 195 |
|
|
2020
Q2 | $281K | Buy |
4,070
+449
| +12% | +$31K | 0.07% | 206 |
|
|
2020
Q1 | $228K | Buy |
+3,621
| New | +$228K | 0.07% | 194 |
|
|
2017
Q1 | – | Sell |
-276
| Closed | -$9K | – | 244 |
|
|
2016
Q4 | $9K | Buy |
+276
| New | +$9K | 0.01% | 391 |
|